Receive The Newest Study Notifications

Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the enrollment of the first patient in the Phase 3 FALCON trial of bardoxolone methyl (bardoxolone) in patients with autosomal dominant polycystic kidney disease...

The Development Operations Centre supports the development of AstraZeneca’s innovative medicines and hosts clinical trial experts focussed on core therapeutic areas: oncology, cardiovascular, renal and metabolism, and respiratory AstraZeneca has launched its clinical...

May 30, 2019 01:00 UTC Results Confirm the Efficacy of CureApp’s Nicotine Dependence Treatment Application TOKYO--(BUSINESS WIRE)-- Results from the world’s first randomized control study to examine digital therapeutic smoking cessation programs were presented on May...

- Data to be presented at the American Society of Clinical Oncology Annual Meeting - - Underscores importance of genetic testing to guide precision medicine treatment and improve family screening Researchers from Invitae (NYSE: NVTA), a leading medical genetics...

The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the 2018 edition of Meds Pipeline Monitor. This annual publication provides a snapshot of the new...

Stellarex is the only low-dose [1] drug-coated balloon (DCB) to demonstrate a significant treatment effect and high safety profile through 3 years ILLUMENATE Pivotal trial showcases durable primary patency (maintained blood flow) in the most complex patient pool...

Through this research, Prof. Tzenios hopes to prove his "Friendly LDL Theory" LONDON, May 30, 2019 /PRNewswire/ -- Hon. Prof. Dr. Nicolas Tzenios (creator of "KetoTv" and Chairman of TRCGEN+ medical research hub) has signed on to conduct a clinical trial with KGK...

The study is designed to measure the impact of long-term, high-intensity aerobic exercise Cleveland: The National Institutes of Health has awarded Cleveland Clinic researcher Jay Alberts, Ph.D, a 5-year, $3 million grant to conduct a multi-site clinical trial to study...

Following recent reports exposing prominent issues with generic drugs, attorney and rare disease patient Candance Lerman is highlighting the need for safety and efficacy testing surrounding off-label treatments. Lerman is calling on pharmaceutical companies to run...

Clear and encouraging percentage changes over baseline in trabecular volumetric bone mineral density measured at the radius at an early readout Expect topline 12 month data from the blinded arms of study to be available in fourth quarter 2019 A call for analysts and...

Longboat Clinical is pleased to announce a new partnership with the Avoca Quality Consortium (AQC) to make an extensive suite of quality management tools available to hospitals and clinics participating in clinical studies. The AQC, a precompetitive collaborative...

Over the past year Novartis, in collaboration with the MIT Center for Wireless Networks and Mobile Computing, has tested a novel technology for passive, contactless monitoring of physiological signals that may be used to monitor clinical trial patients in their homes....

Dose escalation phase of the study completed up to the maximum planned dose of  20 mg/kg without dose-limiting toxicities (DLT) to date Preliminary patient pharmacodynamic (PD) data support continued clinical development Phase 1 study design featured at ASCO 2019...

The New Drug is a Category 1 innovative drug of the PRC developed by the Group. Representative Image Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China's prescription drug market, announced the third generation...

Akero Therapeutics, Inc., a biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases, today announced that it has screened the first patient for its Phase 2a clinical trial evaluating...

The vast majority of clinical trial sponsors agree that unifying clinical data systems would accelerate study execution, improve study quality and lead to significant cost savings, yet few actually use this data to their benefit. In this free webinar, learn how to...

Proof of Concept Trial Reveal Significant Reduction in Cellulite with No Bruising, No Swelling and No Downtime after single 20-Minute non-invasive Procedure; Justifies proceeding with Pivotal Trial. Soliton, Inc., (SOLY) ("Soliton" or the "Company"), a medical device...

Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of the American Society of Cell & Gene Therapy (ASGCT), researchers at Baylor College of...

Neuropore Therapies, Inc. announced today that partner UCB initiated a multicenter clinical trial in Parkinson’s disease patients with UCB0599 in the United States of America. UCB0599, an alpha-synuclein misfolding inhibitor, is a therapeutic candidate arising from...

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that GtreeBNT ('Gtree'), its licensee for RGN-137 topical wound healing gel,...